SomnoMed Ltd (ASX: SOM) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

SomnoMed Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $185.38 million
P/E Ratio 136.99
Dividend Yield N/A
Shares Outstanding 82.76 million
Earnings per share -0.014
Dividend per share N/A
Year To Date Return -4.68%
Earnings Yield 0.73%
Franking N/A
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

SomnoMed Ltd (ASX: SOM)
Latest News

SOM ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About SomnoMed Ltd

SomnoMed Ltd produces and sells oral treatment of sleep-related disorder devices. It manufactures and designs premium oral appliances for the treatment of sleep-disordered breathing relieving conditions. Its products include SomnoDent oralappliance for obstructive sleep apnea; and SomnoBrux, a mouthguard, which protects patients from teeth grinding damage, as well as SomTabs for cleaning its devices. Its geographical segments include North America, Europe, and Asia-Pacific.Business operations consist of the production and sale of products treating sleep-disordered breathing, which is the only reportable segment. Substantial revenue is realized from the European region.

SOM Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
19 Jan 2022 $2.24 $0.16 7.69% 938 $2.13 $2.25 $2.13
18 Jan 2022 $2.08 $0.00 0.00% 2,663 $2.07 $2.08 $2.07
14 Jan 2022 $2.08 $-0.01 -0.48% 6,140 $2.15 $2.15 $2.08
13 Jan 2022 $2.09 $-0.05 -2.34% 2,246 $2.08 $2.09 $2.07
12 Jan 2022 $2.14 $0.06 2.88% 1,320 $2.15 $2.15 $2.14
11 Jan 2022 $2.08 $-0.07 -3.26% 5,280 $2.10 $2.10 $2.08
10 Jan 2022 $2.15 $0.06 2.87% 106,175 $2.10 $2.15 $2.10
07 Jan 2022 $2.09 $-0.11 -5.00% 2,335 $2.14 $2.14 $2.05
06 Jan 2022 $2.20 $-0.15 -6.38% 164,575 $2.20 $2.20 $2.20
31 Dec 2021 $2.35 $0.00 0.00% 2,051 $2.35 $2.35 $2.35
30 Dec 2021 $2.35 $0.05 2.17% 16,950 $2.33 $2.35 $2.33
29 Dec 2021 $2.30 $0.08 3.60% 8,796 $2.28 $2.30 $2.28
23 Dec 2021 $2.22 $0.09 4.23% 1,800 $2.22 $2.22 $2.22

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
29 Nov 2021 Gaetano (Guy) Russo Buy 217 $499,100
On-market trade.
27 Sep 2021 Hamish Corlett Buy 53 $129,028
On-market trade.
21 Sep 2021 Hilton Brett Buy 34 $81,263
On-market trade.
20 Sep 2021 Hamish Corlett Buy 661 $1,541,332
On-market trade.
26 Aug 2021 Hamish Corlett Buy 93 $211,541
On-market trade.
06 Aug 2021 Hilton Brett Issued 185 $28,490
Issue of securities.
06 Aug 2021 Michael Gordon Issued 185 $28,490
Issue of securities.
06 Aug 2021 Gaetano (Guy) Russo Issued 370 $56,980
Issue of securities.
06 Aug 2021 Neil Verdal-Austin Issued 910 $140,140
Issue of securities.
06 Aug 2021 Amrita Blickstead Issued 185 $28,490
Issue of securities.
06 Aug 2021 Karen Borg Issued 185 $28,490
Issue of securities.
06 Aug 2021 Hamish Corlett Issued 185 $28,490
Issue of securities.
25 May 2021 Hamish Corlett Buy 516 $1,132,179
On-market trade.
25 May 2021 Hilton Brett Buy 36 $81,069
On-market trade.
17 May 2021 Hamish Corlett Buy 17 $38,143
On-market trade.
03 May 2021 Hamish Corlett Buy 137 $284,095
On-market trade.
30 Mar 2021 Hamish Corlett Buy 766 $1,455,576
On-market trade.
17 Mar 2021 Hamish Corlett Buy 1 $2,035,380
On-market trade.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Michael Gordon Non-Executive Director Aug 2020
Mr Gordon was most recently the CFO of Rokt. Rokt is a high-growth marketing technology company with more than US$200m in revenue, more than 300 employees and offices in Sydney, New York, Tokyo, Singapore and Auckland. Michael remains as an advisor to Rokt. Prior to Rokt, Michael was the Group CFO and MD of Group Services for Greenlit Brands Pty Limited. Greenlit Brands grew from a turnover of A$250m (Freedom) to a A$2.4 billion vertically integrated retailer based in Australia and New Zealand and included the brands, Freedom, Snooze, Fantastic, Plush, OMF, Best & Less and Harris Scarfe. Prior to Greenlit Brands, Michael spent ten years with PricewaterhouseCoopers in South Africa, the United Kingdom and Australia specializing in the Retail industry with experience in Audit, Taxation M&A and IPO's.
Mr Gaetano (Guy) Alfred Gerrard Russo Non-Executive ChairmanNon-Executive Director Aug 2020
Mr Russo has served as CEO, Wesfarmers Department Store Division (Kmart & Target); Managing Director, Kmart Australia & NZ; President, McDonald's Greater China; CEO McDonald's Australia Ltd and Chairman of Ronald McDonald House Children's Charities. Guy is perhaps most well known in Australia for his leadership in turning Kmart into the largest and most profitable retail department store in the country. He has been a member of YPO since 2006, served as a member of the Business Council of Australia, and won industry awards for leadership in diversity in employment.
Mr Hilton Brett Non-Executive Director Aug 2020
Mr Brett is an Operating Advisor at TDM Growth Partners (TDM), a private global investment firm founded in 2004, with offices in Sydney and New York which invests in fast growing companies run by passionate management teams. Prior to joining TDM, Hilton was the Co-CEO of Accent Group Limited (AX1), formerly RCG Corporation Ltd, which is the regional leader in the retail and distribution of performance and lifestyle footwear Australia and New Zealand. Hilton joined RCG in 2006 when the business had a market capitalisation of $8m. Over the 12 years from 2006 to 2018, the team grew the business to a $800m market capitalisation and delivered total shareholder returns in excess of 25% CAGR. Hilton has over 25 years experience as CEO of multiple consumer businesses with proven skills in growing the businesses and delivering outstanding returns for shareholders.
Mr Hamish James Corlett Non-Executive Director May 2018
Mr Corlett is a founder and director of TDM Growth Partners, a leading private investment firm specializing in long term investments in high growth companies globally. Prior to TDM, Hamish worked as an Investment Manager at Caledonia Investments, a global fund manager. Hamish also worked in London in an operating role for an ecommerce start up and in Sydney at Caliburn Partnership (now Greenhill) in corporate advisory.
Mr Neil Verdal-Austin Chief Executive OfficerManaging Director Nov 2019
Mr Verdal-Austin is a experienced and business focused individual, having worked for medical device companies in South Africa, the UK and in Australia for over 25 years.
Ms Amrita Blickstead Non-Executive Director Aug 2020
Ms Blickstead is the Chief Operating & Marketing Officer at eBay Australia & New Zealand as well as a member of the Executive Leadership Team. Amrita leads Strategy, Operations, Marketing, Buyer Loyalty, Advertising, Monetization & Consumer Selling. Having worked at eBay for nearly 10 years she has deep ecommerce experience covering multiple roles including leading Small & Medium Business, Shipping, and Cross Border Trade. She is currently on maternity leave from eBay. Prior to eBay, Amrita was a management consultant with Port Jackson Partners, advising on strategic issues predominantly in retail, electricity and construction. She also worked in the Medical Device industry as a Biomedical Engineer at Ventracor and Cochlear as well as the Pharmaceutical industry in Marketing at Eli Lilly and Company in the USA. Amrita also won the Australian Financial Review BOSS Awards for Young Executive of the Year in 2019.
Ms Karen Borg Non-Executive Director Nov 2020
Ms Borg has held senior roles in FTSE 100-250 medical device, technology, consumer products and government services organisations. Karen is currently the Chief Executive Officer for Catholic Healthcare Ltd and prior to this was the CEO of Healthdirect and the inaugural CEO of Jobs for NSW. She was also the former President (Asia Pacific & Middle East) of ResMed (ASX: RMD) and held several senior roles with Johnson & Johnson Medical Devices in Australia and the United States. Karen began her career in the fast-moving consumer goods sector and worked for Goodman Fielder, Nestle and Revlon in global business development and marketing. Karen was previously on the Board of The North Foundation and Interim Chair of the Australian Vaccine Research Alliance. Karen was a NSW finalist for Telstra Business Woman of the Year 2017
Mr Terence Anthony Flitcroft Company Secretary
-
Herve Fievet Chief Financial Officer
-
Terence Anthony Flitcroft Company Secretary
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
HSBC Custody Nominees (Australia) Limited 30,014,342 36.27%
National Nominees Limited 9,616,815 11.62%
Smartequity EIS Pty Ltd 4,666,768 5.64%
Dottie Investments Pty Ltd 3,650,487 4.41%
Citicorp Nominees Pty Limited 2,847,531 3.44%
Belgove Pty Ltd 2,553,265 3.08%
Howarth PAF Pty Ltd <The Howarth Foundation A/C> 2,156,722 2.61%
Ginga Pty Ltd 1,799,045 2.17%
BNP Paribas Nominees Pty Ltd <ACF Clearstream A/C> 1,301,292 1.57%
BNP Paribas Nominees Pty Ltd <IB AU Noms Retail Client DRP> 1,206,009 1.46%
P Neustadt Holdings Pty Ltd <Belgove Super Fund A/C> 1,082,171 1.31%
Timbina Pty Ltd <Timbina Super Fund A/C> 1,073,764 1.30%
Sandhurst Trustees Ltd <Endeavour Asset Mgmt MDA A/C> 942,419 1.14%
REM Medical Pty Ltd <Cocoon Super Fund A/C> 800,641 0.97%
Golden Words Pty Ltd 775,399 0.94%
Thirty Sixth Vilmar Pty Ltd 561,148 0.68%
J P Morgan Nominees Australian Pty Limited 546,841 0.66%
Mr Edward Palmisano 534,631 0.65%
The Mulloon Institute Ltd 533,048 0.64%
Howarth PAF Pty Ltd <Howarth Charitable Fund A/C> 523,771 0.63%

Profile

since

Note